Integer (US:ITGR) Businesswire·2025-12-17 17:05Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation for allegedly misleading investors regarding its business performance and sales forecasts during the specified Class Period [1][5]. Group 1: Company Performance - On October 23, 2025, Integer reduced its full-year 2025 sales guidance to a range of $1.840 billion to $1.854 billion, which was below prior expectations [3]. - The company anticipated net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026, indicating a slowdown in growth [3]. - Management revealed that sales of three new products, including two electrophysiology devices, were expected to decline in 2026 due to slower market adoption [3]. Group 2: Stock Impact - Following the announcement of reduced sales guidance, Integer's stock price fell by $35.22 per share, or 32.3%, closing at $73.89 per share on October 23, 2025 [4]. Group 3: Allegations in the Lawsuit - The lawsuit alleges that Integer made materially false and misleading statements about its competitive position in the electrophysiology (EP) manufacturing market [5]. - It is claimed that the company overstated its visibility into customer demand and mischaracterized its EP devices as long-term growth drivers for its Cardio & Vascular segment [5]. - The lawsuit contends that the positive statements made by the company regarding its business and prospects were materially misleading and lacked a reasonable basis [5].